COVID-19 infection and vitamins / Монголын Анагаах Ухаан

ABSTRACT

@#In December 2019, a group of patients with severe acute respiratory syndrome were diagnosed in Wuhan, Hubei Province, China. The virus that causes the disease is called SARS-CoV-2, and COVID-19 is spreading rapidly from Asia to Europe and around the world. New epidemics, such as the new coronavirus, acute respiratory syndrome (SARS-CoV), Middle East respiratory syndrome (MERS-CoV), and H1N1 influenza A, have been a warning to global health organizations. However, none of these pathogens have had such a catastrophic impact worldwide as the novel coronavirus SARS-CoV-2. RNA viruses known to possess very high mutation rate, which is associated with increased virulence and variability. This feature can also be seen in COVID-19, which has over 50 million cases with a mortality rate of 2.5% in 217 countries. The clinical spectrum of COVID-19 ranges from asymptomatic carriage, mild upper respiratory tract infection (URTI), severe viral pneumonia to acute respiratory distress syndrome (ARDS) and death. Research has led to identification of the angiotensin-converting enzyme (ACE) 2 as the cell-entry receptor for SARS-CoV-2. However, despite these findings, systematic studies of viral dynamics and the immune response of infected individuals have not been fully established.</br> Coronavirus vaccines are being developed around the world and are expected to produced in 2021, according to Australian researchers. However, there is a urgent need for evidence-based treatment against SARS-CoV-2.</br> This article summarizes the many studies that have been conducted on the effects of vitamins and minerals in the treatment of coronavirus infections.